Puma Biotechnology PBYI reported its Q1 earnings results on Thursday, May 4, 2023 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Puma Biotechnology beat estimated earnings by 228.57%, reporting an EPS of $0.09 versus an estimate of $-0.07.
Revenue was up $7.10 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 19.35% drop in the share price the next day.
Here's a look at Puma Biotechnology's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.01 | -0.05 | -0.17 | |
| EPS Actual | -0.07 | 0.05 | 0.28 | -0.01 |
| Revenue Estimate | 57.06M | 50.13M | 51.97M | 45.07M |
| Revenue Actual | 65.70M | 57.10M | 59.50M | 45.70M |
To track all earnings releases for Puma Biotechnology visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
